Class summary at a glance.

Every drug in the Barbiturate class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 8tracked in Part D
CY24 Part D spend: —combined across class
Total Rx claims: —— unique beneficiaries
Generic mfrs (active): 25across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Butal/Apap/Caff

— Part D claims (CY24) · First FDA approval: 2023-03-14

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Butal/Apap/Caffeine

— Part D claims (CY24) · First FDA approval: 2025-01-02

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Butalbital and Acetaminophen

Brand: ALLZITAL · — Part D claims (CY24) · First FDA approval: 1999-06-03

8 generic mfrs 27 plans require PA

Low NADAC$0.696

→

Avg plan cost$0.975

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Butalbital and Acetaminophen Tablets

Brand: Butalbital and Acetaminophen · — Part D claims (CY24) · First FDA approval: 2017-06-19

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Butalbital, Acetaminophen and Caffeine

— Part D claims (CY24) · First FDA approval: 1987-01-21

15 generic mfrs 83 plans require PA

Low NADAC$0.131

→

Avg plan cost$0.716

Part D spend — 5× spread, current vs floor

Class share

of class CY24 spend

View profile →

Butalbital, Acetaminophen, Caffeine and Codeine

— Part D claims (CY24) · First FDA approval: 2004-07-01

2 generic mfrs 46 plans require PA

Low NADAC$0.878

→

Avg plan cost$2.30

Part D spend — 3× spread, current vs floor

Class share

of class CY24 spend

View profile →

Butalbital, Acetaminophen, and Caffeine Capsules

Brand: Butalbital, Acetaminophen, and Caffeine · — Part D claims (CY24) · First FDA approval: 2019-12-17

Brand-only (no generics)

Low NADAC$0.311

→

Avg plan cost$0.311

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Butalbital/Acetaminophen/Caffeine

— Part D claims (CY24) · First FDA approval: 2023-01-03

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.